Based on recent observations, it was proposed that blocking cGAS/STING might show some efficacy in inflammation driven by sepsis [26], although to achieve a robust clinical remission in this disease, it might require combining cGAS/STING inhibitors with drugs targeted to TLRs and other DNA sensing pathways. The gene discussed is STING1; the disease is Sepsis.